Alfresa Holdings Corporation
OTC: ARHCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Industrials
- Industry
- Medical - Distribution
- CEO
- Ryuji Arakawa
- Employees
- 12,452
- Headquarters
- Tokyo, Japan
- IPO year
- 2007
- Market cap
- $2.2B
- Website
- http://www.alfresa.com
Loading ARHCF…
Loading profile data…Frequently asked questions about ARHCF
What does Alfresa Holdings Corporation (ARHCF) do?
Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, Manufacturing, and Medical-...
Where does ARHCF trade?
Alfresa Holdings Corporation (ARHCF) trades on the Other OTC.
What sector is ARHCF in?
Alfresa Holdings Corporation (ARHCF) operates in the Industrials sector, specifically in the Medical - Distribution industry.
Who is the CEO of Alfresa Holdings Corporation?
Ryuji Arakawa is the chief executive officer of Alfresa Holdings Corporation (ARHCF).
Where is Alfresa Holdings Corporation headquartered?
Alfresa Holdings Corporation is headquartered in Japan.
Does ARHCF pay a dividend?
Yes — Alfresa Holdings Corporation (ARHCF) paid a trailing twelve-month dividend of USD 0.46 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ARHCF go public?
Alfresa Holdings Corporation (ARHCF) completed its initial public offering in 2007.